Samuel Adeosun

Dr. Samuel Adeosun


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2022 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
SASamuel Adeosun
Samuel Adeosun
The United States opioid epidemic is fueled by illicit opioid abuse and prescription opioid misuse and abuse. Consequently, cases of opioid use disorder (OUD, opioid addiction), opioid overdose, and related deaths have increased since the year 2000. Naloxone is an opioid antagonist that rapidly reverses opioid intoxication to prevent death from overdose. It is one of the major risk mitigation strategies recommended in the 2016 Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain. However, despite the exponential increase in dispensing and distribution of naloxone, opioid overdose and related deaths have continued to increase; suggesting that the increased naloxone supply still lags the need. This discordance is attributed at least in part to the negative attitude toward naloxone, which is based on the belief that naloxone is only meant for “addicts” and “abusers” (OUD patients). This negative attitude or so-called naloxone stigma is therefore considered a major barrier for naloxone distribution and consequently, overdose-death prevention efforts. This article presents evidence that challenges common assertions about OUD stigma being the sole and direct driving force behind naloxone stigma, and the purported magnitude of the barrier that naloxone stigma constitutes for naloxone distribution programs among the stakeholders (patients, pharmacists, and prescribers). The case was then made to operationalize and quantify the construct among the stakeholders to determine the extent to which OUD stigma drives naloxone stigma, and the relative impact of naloxone stigma as a barrier for naloxone distribution efforts.

26 November 2024 in INNOVATIONS in pharmacy
Verified
Journal Article
Open access
PDF file
SASamuel Adeosun
Samuel Adeosun
Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, and review articles that focus on the leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy is an academic, peer reviewed, open-access journal. Sponsored by U of MN College of Pharmacy Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy. A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, review articles, and student projects that focus on leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy.

8 November 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
SASamuel Adeosun
Samuel Adeosun

18 July 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
SASamuel Adeosun
Samuel Adeosun
ZAZena R. Ahmed
Zena R. Ahmed
Introduction: The effects of the coronavirus disease 2019 (COVID‐19) pandemic on scholarly outcomes and research focus of schools of pharmacy (SOPs) have not been studied.Objectives: To determine how objective measures of scholarly outcomes and research focus changed in pharmacy practice among SOPs, within geographic regions, during the COVID‐19 pandemic.Methods: SOPs were included if they appeared on the National Institutes of Health (NIH) funding list in all four index years (2018–2019: pre‐pandemic and 2020–2021: pandemic) and ranked among the top 50 at least once between 2018 and 2021. Names of pharmacy practice faculty were obtained from the American Association of Colleges of Pharmacy (AACP) directory. The publication records of each SOP were obtained from Scopus. Scholarly outcome measures were scholarly activity ratio (SAR; proportion of faculty members who published) and scholarly output (SO; number of documents published). Data was analyzed using Microsoft Excel, VOSviewer®, and Python. Statistical analysis was done in R using a mixed effects model, with the pandemic and geographic regions as fixed effects, and SOPs as the random effect.Results: Fifty‐five SOPs and 1343 faculty members were included. Neither the pandemic nor geographic region had significant effects on SAR. However, both variables had significant effects on SO, as demonstrated by an increase in the Midwest during the pandemic (p < 0.05). Documents published increased from 2755 to 3001 during the pandemic. This 8.9% increase was lower than a historical average biennial increase of 24.9%. COVID‐19 was the top new research topic, constituting 56.5% of the increase over the pre‐pandemic period. Of these COVID‐19 publications, 20.9% were education‐related.Conclusion: Pharmacy practice faculty engaged in COVID‐19 research that focused predominantly on education. Scholarly‐active faculty were resilient, but their output was lower than expected based on historical trends. These results support the need to adjust tenure and promotion benchmarks and/or timelines related to scholarly output, especially for tenure‐track faculty with probationary periods spanning these pandemic years.

23 August 2025 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
SASamuel Adeosun
Samuel Adeosun
NSNickalus C. Smith
Nickalus C. Smith
NANorvinyo A. Abiti
Norvinyo A. Abiti
SBSydney A. Borst
Sydney A. Borst
JWJacob K. Walters
Jacob K. Walters
KBKyle J. Burghardt
Kyle J. Burghardt

25 April 2022 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
PDF file
SASamuel Adeosun
Samuel Adeosun
Objective. To determine whether there are differences in the performance and quality of multiple-choice items with opposite stem orientations (positive or negative), based on a novel item quality measure and conventional psychometric parameters. Methods. A retrospective study was conducted on multiple-choice assessment items in professional years 2 and 3 for Pharmacotherapy and related courses administered between August 2018 and December 2019. Conventional psychometric parameters (difficulty and discrimination indices), average response time, non-functional distractor percentage, and a novel measure of item quality of negatively worded items (NWIs) were compared with those of control, positively worded items (PWIs) (N=103 each). This novel measure uses difficulty and discrimination in tandem for the decision to reject, review, or retain items in an assessment. Continuous and categorical variables were analyzed with Mann-Whitney U and Chi-square tests, respectively. The relationship between difficulty and discrimination was tested with Spearman correlation, and differences in correlation coefficients between PWIs and NWIs were tested with Fisher’s r-to-z transformation. Results. Stem orientation was not significantly associated with the novel measure of item quality. Also, there were no significant differences between PWIs and NWIs in any of the psychometric parameters. There were significant, negative correlations between difficulty and discrimination indices in both groups, and the correlation coefficients were significantly stronger in PWIs versus NWIs. Conclusion. Items with opposite stem orientations are neither different in the novel item quality measure nor in conventional measures of performance and quality, except in difficulty-discrimination relationships. These suggest that NWIs should be used when necessary, but cautiously.